Showing results (601-610 of 3,253) with videos related to

Sort By:
Pageof 326
Kardiologia Polska|October 6, 2020
Heart failure with preserved ejection fraction after the PARAGON-HF trial results: current knowledge and future directionsMałgorzata Lelonek
Kardiologia Polska|October 6, 2020
New hope for patients and challenges for the multidisciplinary arrhythmia team: a hybrid convergent approach for atrial fibrillation treatmentPiotr Buchta, Radosław Sierpiński, Krzysztof Myrda, et al.
Kardiologia Polska|January 16, 2019
Left ventricular contractile reserve in stress echocardiography: the bright side of the forceEugenio Picano, Tonino Bombardini, Tamara Kovačević Preradović, et al.
Kardiologia Polska|December 7, 2019
Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertaintiesLinda Lóczi, János Kappelmayer, Tünde Tarr, et al.
Kardiologia Polska|October 31, 2019
Rho GTPase‑activating protein 1 promotes apoptosis of myocardial cells in an ischemic cardiomyopathy modelXuezhi Zhang, Jun Guan, Minglei Guo, et al.
Kardiologia Polska|February 12, 2019
Association between carotid-femoral pulse wave velocity and overall cardiovascular risk score assessed by the SCORE system in urban Polish populationMateusz Podolec, Aleksander Siniarski, Andrzej Pająk, et al.
Kardiologia Polska|February 20, 2018
[Coordinated heart failure care in Poland: towards optimal organisation of the health care system]Jadwiga Nessler, Adam Kozierkiewicz, Andrzej Gackowski, et al.
Kardiologia Polska|February 20, 2018
[Transthoracic echocardiography in adults - guidelines of the Working Group on Echocardiography of the Polish Cardiac Society]Piotr Lipiec, Janusz Bąk, Wojciech Braksator, et al.
Kardiologia Polska|November 24, 2017
Clinical characteristics, and in-hospital and long-term outcomes of stable angina treatment in patients below and over 40 years of age (from the PRESAGE registry)Przemysław Trzeciak, Piotr Desperak, Aneta Ciślak, et al.
Kardiologia Polska|January 30, 2020
Anthracycline-induced cardiotoxicity prevention with angiotensin-converting enzyme inhibitor ramipril in women with low-risk breast cancer: results of a prospective randomized studyAgnieszka Słowik, Paweł Jagielski, Paweł Potocki, et al.
Pageof 326